Elevated blood markers 1 year before manifestation of malignant glioma
نویسندگان
چکیده
منابع مشابه
The role of relative cerebral blood volume obtained from Perfusion Weighted Imaging-MRI in glioma tumor grading before surgery
Introduction: Glioma is the most common type of brain malignancy among adults. Treatment for this type of tumor involves surgery, radiotherapy, and in higher grades, including chemotherapy. The precise grading of the tumor is critical for treatment planning and prognosis determining. Considering the possibility of problems such as errors in tissue sampling during surgery, as we...
متن کاملExpression of TIP-1 Confers Radioresistance of Malignant Glioma Cells
BACKGROUND Malignant gliomas represent one group of tumors that poorly respond to ionizing radiation (IR) alone or combined with chemotherapeutic agents because of the intrinsic or acquired resistance. In this study, TIP-1 was identified as one novel protein that confers resistance of glioma cells to IR. METHODOLOGY/PRINCIPAL FINDINGS Meta-analysis indicated that high TIP-1 expression levels ...
متن کاملTemozolomide in malignant glioma
Glioblastoma multiforme WHO grade IV (GBM) is the most aggressive malignant glioma and the most frequent primary tumor of the central nervous system. The median survival of newly diagnosed GBM patients was between 9 to 12 months prior to treatment with temozolomide being introduced. Primary resection that is as complete as possible is recommended for malignant glioma. Conventional fractionated ...
متن کاملImmunotherapy for malignant glioma
Malignant gliomas (MG) are the most common type of primary malignant brain tumor. Most patients diagnosed with glioblastoma (GBM), the most common and malignant glial tumor, die within 12-15 months. Moreover, conventional treatment, which includes surgery followed by radiation and chemotherapy, can be highly toxic by causing nonspecific damage to healthy brain and other tissues. The shortcoming...
متن کاملMalignant Glioma Therapy
Accepted, February 12, 2003. MALIGNANT GLIOMAS ARE among the most challenging of all cancers to treat successfully, being characterized not only by aggressive proliferation and expansion but also by inexorable tumor invasion into distant brain tissue. Although considerable progress has been made in the treatment of these tumors with combinations of surgery, radiotherapy, and chemotherapy, these...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Neuro-Oncology
سال: 2010
ISSN: 1522-8517,1523-5866
DOI: 10.1093/neuonc/noq034